Healthcare provider profile · identity verified

Robert Scott Magley, MD

Family Practice · EBENSBURG, PA · NPI 1013945047

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	117
Levothyroxine Sodium	Levothyroxine Sodium	411	76
Losartan Potassium	Losartan Potassium	300	75
Diclofenac Sodium	Diclofenac Sodium	298	75
Amlodipine Besylate	Amlodipine Besylate	290	74
Montelukast Sodium	Montelukast Sodium	271	75
Prednisone	Prednisone	257	162
Pantoprazole Sodium	Pantoprazole Sodium	241	69
Fluticasone Propionate	Fluticasone Propionate	224	95
Metformin Hcl	Metformin Hcl	211	49
Cefuroxime	Cefuroxime Axetil	204	151
Dexamethasone	Dexamethasone	198	135
Lisinopril	Lisinopril	186	39
Rosuvastatin Calcium	Rosuvastatin Calcium	166	40
Famotidine	Famotidine	165	49
Meloxicam	Meloxicam	161	54
Ozempic	Semaglutide	148	21
Omeprazole	Omeprazole	138	32
Eliquis	Apixaban	130	26
Furosemide	Furosemide	127	48
Metoprolol Tartrate	Metoprolol Tartrate	126	31
Potassium Chloride	Potassium Chloride	118	28
Clopidogrel	Clopidogrel Bisulfate	114	22
Gabapentin	Gabapentin	112	24
Sertraline Hcl	Sertraline Hcl	108	19
Tamsulosin Hcl	Tamsulosin Hcl	105	28
Metoprolol Succinate	Metoprolol Succinate	98	22
Fluconazole	Fluconazole	97	65
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	96	40
Trazodone Hcl	Trazodone Hcl	93	27
Hydrochlorothiazide	Hydrochlorothiazide	92	25
Duloxetine Hcl	Duloxetine Hcl	90	suppressed
Warfarin Sodium	Warfarin Sodium	85	17
Allopurinol	Allopurinol	81	22
Celecoxib	Celecoxib	77	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	15
Jardiance	Empagliflozin	71	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	70	47
Pravastatin Sodium	Pravastatin Sodium	69	14
Finasteride	Finasteride	68	15
Atenolol	Atenolol	67	15
Escitalopram Oxalate	Escitalopram Oxalate	60	12
Alprazolam	Alprazolam	57	suppressed
Meclizine Hcl	Meclizine Hcl	57	29
Simvastatin	Simvastatin	57	13
Citalopram Hbr	Citalopram Hydrobromide	54	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	54	34
Synthroid	Levothyroxine Sodium	49	13
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Tramadol Hcl	Tramadol Hcl	48	17
Ondansetron Odt	Ondansetron	45	39
Spironolactone	Spironolactone	45	suppressed
Azelastine Hcl	Azelastine Hcl	44	23
Ezetimibe	Ezetimibe	44	12
Lorazepam	Lorazepam	43	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	39	11
Azithromycin	Azithromycin	38	32
Mupirocin	Mupirocin	38	27
Naproxen	Naproxen	38	28
Digoxin	Digoxin	36	suppressed
Dutasteride	Dutasteride	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	23
Levofloxacin	Levofloxacin	31	27
Diazepam	Diazepam	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	27
Cephalexin	Cephalexin	27	25
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Amoxicillin	Amoxicillin	26	20
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	16
Topiramate	Topiramate	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	21	11
Dicyclomine Hcl	Dicyclomine Hcl	21	15
Minocycline Hcl	Minocycline Hcl	21	11
Aripiprazole	Aripiprazole	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Chlorzoxazone	Chlorzoxazone	19	11
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Torsemide	Torsemide	19	suppressed
Glipizide	Glipizide	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	11
Acyclovir	Acyclovir	16	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Enalapril Maleate	Enalapril Maleate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Metolazone	Metolazone	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Glyburide	Glyburide	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Metronidazole	Metronidazole	13	13
Mounjaro	Tirzepatide	13	suppressed
Temazepam	Temazepam	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Acetic Acid	Acetic Acid	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error